KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opko Health (OPK) Depreciation and Depletion (2016 - 2025)

Historic Depreciation and Depletion for Opko Health (OPK) over the last 11 years, with Q3 2025 value amounting to $3.2 million.

  • Opko Health's Depreciation and Depletion fell 1351.35% to $3.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.1 million, marking a year-over-year decrease of 1349.69%. This contributed to the annual value of $15.6 million for FY2024, which is 1917.1% down from last year.
  • As of Q3 2025, Opko Health's Depreciation and Depletion stood at $3.2 million, which was down 1351.35% from $3.6 million recorded in Q2 2025.
  • Over the past 5 years, Opko Health's Depreciation and Depletion peaked at $8.0 million during Q2 2021, and registered a low of $3.2 million during Q3 2025.
  • Moreover, its 5-year median value for Depreciation and Depletion was $4.9 million (2022), whereas its average is $5.0 million.
  • Its Depreciation and Depletion has fluctuated over the past 5 years, first surged by 958.9% in 2021, then plummeted by 3500.0% in 2022.
  • Quarter analysis of 5 years shows Opko Health's Depreciation and Depletion stood at $6.6 million in 2021, then fell by 25.76% to $4.9 million in 2022, then decreased by 8.16% to $4.5 million in 2023, then dropped by 17.78% to $3.7 million in 2024, then fell by 13.51% to $3.2 million in 2025.
  • Its Depreciation and Depletion was $3.2 million in Q3 2025, compared to $3.6 million in Q2 2025 and $3.6 million in Q1 2025.